Aptinyx Inc. (APTX): Price and Financial Metrics


Aptinyx Inc. (APTX)

Today's Latest Price: $3.14 USD

0.03 (0.96%)

Updated Sep 25 4:00pm

Add APTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 233 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

APTX Stock Summary

  • Aptinyx Inc's stock had its IPO on June 21, 2018, making it an older stock than just 5.42% of US equities in our set.
  • For APTX, its debt to operating expenses ratio is greater than that reported by merely 0.34% of US equities we're observing.
  • APTX's price/sales ratio is 46.64; that's higher than the P/S ratio of 95.67% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Aptinyx Inc are FPRX, RGNX, BLUE, AGIO, and CLLS.
  • APTX's SEC filings can be seen here. And to visit Aptinyx Inc's official web site, go to www.aptinyx.com.
APTX Daily Price Range
APTX 52-Week Price Range

APTX Stock Price Chart Technical Analysis Charts


APTX Price/Volume Stats

Current price $3.14 52-week high $5.28
Prev. close $3.11 52-week low $1.60
Day low $3.05 Volume 118,184
Day high $3.31 Avg. volume 315,356
50-day MA $3.68 Dividend yield N/A
200-day MA $3.52 Market Cap 147.46M

Aptinyx Inc. (APTX) Company Bio


Aptinyx Inc. develops therapeutics for neurological disorders. The company is focused on the development of drugs that interact with the NMDA receptor, and the company says it will use the funds to advance drugs for chronic pain, post-traumatic stress disorder (PTSD) and cognitive impairment in Parkinson’s disease. The company was founded in 2015 and is based in Evantson, Illinois.


APTX Latest News Stream


Event/Time News Detail
Loading, please wait...

APTX Latest Social Stream


Loading social stream, please wait...

View Full APTX Social Stream

Latest APTX News From Around the Web

Below are the latest news stories about Aptinyx Inc that investors may wish to consider to help them evaluate APTX as an investment opportunity.

Is Aptinyx (NASDAQ:APTX) In A Good Position To Deliver On Growth Plans?

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Yahoo | August 21, 2020

Aptinyx (APTX) Investor Presentation - Slideshow

The following slide deck was published by Aptinyx Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | August 16, 2020

Aptinyx Inc (APTX) CEO Norbert Riedel on Q2 2020 Results - Earnings Call Transcript

Aptinyx Inc (APTX) Q2 2020 Results Conference Call August 13, 2020 05:00 PM ET Company Participants Nick Smith - Senior Director, Corporate Development & IR Norbert Riedel - President & CEO Ashish Khanna - CFO & Chief Business Officer Andy Kidd - COO Kathryn King - SVP, Clinical Development Rolando...

SA Transcripts on Seeking Alpha | August 14, 2020

Aptinyx Reports Second Quarter 2020 Financial Results and Highlights

EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today reported financial results for the second quarter of 2020 and highlighted recent progress across the company’s clinical-stage pipeline of novel NMDA receptor modulators. “Despite the continuing COVID-19 health emergency, we have made important progress in advancing our pipeline of clinical-stag

Business Wire | August 13, 2020

Aptinyx Inc. (APTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Aptinyx Inc. (APTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | August 6, 2020

Read More 'APTX' Stories Here

APTX Price Returns

1-mo -4.85%
3-mo -20.71%
6-mo 45.37%
1-year -11.05%
3-year N/A
5-year N/A
YTD -8.19%
2019 -79.32%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching APTX

Want to see what other sources are saying about Aptinyx Inc's financials and stock price? Try the links below:

Aptinyx Inc (APTX) Stock Price | Nasdaq
Aptinyx Inc (APTX) Stock Quote, History and News - Yahoo Finance
Aptinyx Inc (APTX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7824 seconds.